Search results
Does Atara Biotherapeutics (ATRA) Have the Potential to Rally 204% as Wall Street Analysts Expect?
Zacks via Yahoo Finance· 2 years agoThe mean of analysts' price targets for Atara Biotherapeutics (ATRA) points to a 204.1% upside in...
Atara Biotherapeutics (ATRA) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoAtara Biotherapeutics (ATRA) delivered earnings and revenue surprises of -5.13% and 2.13%,...
Atara (ATRA) Up 11% on Regulatory Update From Blood Cancer Study
Zacks via Yahoo Finance· 8 months agoAtara (ATRA) rises 11% on an update regarding the regulatory pathway for the company's lead product...
Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline
Zacks via Yahoo Finance· 13 hours agoBiogen BIIB entered into a definitive agreement to acquire private biotech, HI-Bio, for a $1.15...
Atara Biotherapeutics (ATRA) Slumps 57% in a Month: Here's Why
Zacks via Yahoo Finance· 6 months agoAtara Biotherapeutics ATRA is a biotech company focused on developing off-the-shelf cell therapies...
Why Atara Biotherapeutics Stock Is Crashing Today
Motley Fool· 2 years agoShares of the next-generation cell therapy company Atara Biotherapeutics (NASDAQ: ATRA) are getting hammered today. Prior to Wednesday's opening bell,...
10 Most Promising Penny Stocks According to Analysts
Insider Monkey via Yahoo Finance· 9 months agoIn this article, we will take a look at the 10 most promising penny stocks according to analysts. To see more such companies, go directly to 5 Most...
Dr. Reddy's (RDY) Q1 Earnings Increase Y/Y, Sales Increase
Zacks via Yahoo Finance· 2 years agoDr. Reddy's Laboratories Limited RDY reported first-quarter fiscal 2023 earnings of 90 cents per...
Acadia's (ACAD) Q2 Earnings & Revenues Surpass Estimates
Zacks via Yahoo Finance· 2 years agoAcadia Pharmaceuticals Inc. ACAD reported a second-quarter 2022 loss of 21 cents per share, narrower...
Acadia (ACAD) Thrives on Nuplazid, Overdependence a Concern
Zacks via Yahoo Finance· 2 years agoAcadia's (ACAD) lead drug, Nuplazid, is approved for treating hallucinations and delusions...